Glenmark Generics entered into an exclusive licensing agreement with Par Pharmaceuticals, USA to market Ezetimibe. The company and Sanofi-Aventis signed license agreement to grant Sanofi-Aventis a ...

If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund ...

TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that the Company has provided notification to The Nasdaq Stock Market, LLC ("Nasdaq") of its intent to voluntarily delist the Company's common ...

The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...

When they came up with “Common Side Effects,” Bennett recalled in a recent interview, he was thinking about their prominence ...

Noida, Uttar Pradesh, India <li /> To acquire R&D center at Saint-Julien-en-Genevois, France <li /> To add Drug Discovery & Preclin ...

Jonathan Wolleben, an analyst from JMP Securities, has initiated a new Buy rating on KalVista Pharmaceuticals (KALV).Invest with Confidence: ...

Experts discuss South Africa’s current vaccine manufacturing capabilities and the steps needed to prepare for future ...

Vermont businesses are weighing in about prospective tariffs. President Donald Trump threatened to place a 25 percent tariff ...

Sophie Copley has spoken to Insider about the “epiphany” which led to the rise of her healthtech company Little Journey.